Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

André Zimerman

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
JAMA Internal Medicine|October 18, 2016
Short-term Effects of High-Dose Caffeine on Cardiac Arrhythmias in Patients With Heart Failure: A Randomized Clinical TrialPriccila Zuchinali, Gabriela C Souza, Maurício Pimentel, et al.
Journal of Electrocardiology|November 28, 2021
Growth/differentiation factor-15 (GDF-15) as a predictor of serious arrhythmic events in patients with nonischemic dilated cardiomyopathyBruna Miers May, Adriano Nunes Kochi, Ana Paula Arbo Magalhães, et al.
Arquivos Brasileiros De Cardiologia|December 21, 2023
Incremental Role of New York Heart Association Class and Cardiopulmonary Exercise Test Indices for Prognostication in Heart Failure: A Cohort StudyPedro Henrique de Borba Engster, André Zimerman, Thomas Schaan, et al.
Journal of the American Heart Association|April 26, 2017
Reporting Clinical End Points and Safety Events in an Acute Coronary Syndrome Trial: Results With Integrated CollectionPatrícia O Guimarães, Renato D Lopes, Susanna R Stevens, et al.
JAMA Cardiology|July 10, 2024
Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical TrialAndré Zimerman, Eugene Braunwald, Jan Steffel, et al.
JAMA Cardiology|December 8, 2022
Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart Failure: A Secondary Analysis of the PARADIGM-HF TrialLuis E Rohde, André Zimerman, Muthiah Vaduganathan, et al.
Arquivos Brasileiros De Cardiologia|October 8, 2025
Disease-Modifying Therapies for Transthyretin Amyloid Cardiomyopathy: A Systematic Review and Meta-AnalysisLigia Carolina Facin, Igor Pacheco Fiuza Romeiro, Kaushiki Sapahia, et al.
NEJM Evidence|December 24, 2024
Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with EvolocumabAndré Zimerman, Michelle L O'Donoghue, Xinhui Ran, et al.
The New England Journal of Medicine|April 8, 2024
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular RiskBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
ESC Heart Failure|February 22, 2023
Functional assessment based on cardiopulmonary exercise testing in mild heart failure: A multicentre studyAndré Zimerman, Anderson D da Silveira, Marina S Borges, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
JAMA Internal Medicine|October 18, 2016
Short-term Effects of High-Dose Caffeine on Cardiac Arrhythmias in Patients With Heart Failure: A Randomized Clinical TrialPriccila Zuchinali, Gabriela C Souza, Maurício Pimentel, et al.
Journal of Electrocardiology|November 28, 2021
Growth/differentiation factor-15 (GDF-15) as a predictor of serious arrhythmic events in patients with nonischemic dilated cardiomyopathyBruna Miers May, Adriano Nunes Kochi, Ana Paula Arbo Magalhães, et al.
Arquivos Brasileiros De Cardiologia|December 21, 2023
Incremental Role of New York Heart Association Class and Cardiopulmonary Exercise Test Indices for Prognostication in Heart Failure: A Cohort StudyPedro Henrique de Borba Engster, André Zimerman, Thomas Schaan, et al.
Journal of the American Heart Association|April 26, 2017
Reporting Clinical End Points and Safety Events in an Acute Coronary Syndrome Trial: Results With Integrated CollectionPatrícia O Guimarães, Renato D Lopes, Susanna R Stevens, et al.
JAMA Cardiology|July 10, 2024
Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical TrialAndré Zimerman, Eugene Braunwald, Jan Steffel, et al.
JAMA Cardiology|December 8, 2022
Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart Failure: A Secondary Analysis of the PARADIGM-HF TrialLuis E Rohde, André Zimerman, Muthiah Vaduganathan, et al.
Arquivos Brasileiros De Cardiologia|October 8, 2025
Disease-Modifying Therapies for Transthyretin Amyloid Cardiomyopathy: A Systematic Review and Meta-AnalysisLigia Carolina Facin, Igor Pacheco Fiuza Romeiro, Kaushiki Sapahia, et al.
NEJM Evidence|December 24, 2024
Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with EvolocumabAndré Zimerman, Michelle L O'Donoghue, Xinhui Ran, et al.
The New England Journal of Medicine|April 8, 2024
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular RiskBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
ESC Heart Failure|February 22, 2023
Functional assessment based on cardiopulmonary exercise testing in mild heart failure: A multicentre studyAndré Zimerman, Anderson D da Silveira, Marina S Borges, et al.
Pageof 4